MedPath
TGA Approval

VEKLURY remdesivir 100 mg powder for injection vial (338419)

338419

VEKLURY remdesivir 100 mg powder for injection vial

Gilead Sciences Pty Ltd

July 10, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01929-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01927-1

Active Ingredients

remdesivir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VEKLURY remdesivir 100 mg powder for injection vial (338419) - TGA 批准文号 | MedPath